156 related articles for article (PubMed ID: 3143036)
1. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin.
Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
Microb Pathog; 1987 Jul; 3(1):21-30. PubMed ID: 3143036
[TBL] [Abstract][Full Text] [Related]
2. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
[TBL] [Abstract][Full Text] [Related]
3. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
[TBL] [Abstract][Full Text] [Related]
4. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
Yutsudo T; Honda T; Miwatani T; Takeda Y
Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
[TBL] [Abstract][Full Text] [Related]
5. Studies on shiga-like toxin produced by enterohemorrhagic Escherichia coli: purification and characterization of the toxin and development of methods for identifying the toxin.
Kongmuang U
Med J Osaka Univ; 1989 Mar; 38(1-4):39-49. PubMed ID: 2485395
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
MacLeod DL; Gyles CL
Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539
[TBL] [Abstract][Full Text] [Related]
7. Purification and some properties of a Vero toxin 2 (Shiga-like toxin II) variant (SLT-IIva) of Escherichia coli isolated from infantile diarrhea.
Ohmura M; Cao C; Karasawa T; Okuda J; Kurazono H; Gannon VP; Gyles CL; Takeda Y
Microb Pathog; 1993 Nov; 15(5):399-405. PubMed ID: 8015420
[TBL] [Abstract][Full Text] [Related]
8. Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli O157:H7.
Ito H; Yutsudo T; Hirayama T; Takeda Y
Microb Pathog; 1988 Sep; 5(3):189-95. PubMed ID: 3063913
[TBL] [Abstract][Full Text] [Related]
9. Purification of an Escherichia coli serogroup O157:H7 verotoxin and its detection in North American hemorrhagic colitis isolates.
Dickie N; Speirs JI; Akhtar M; Johnson WM; Szabo RA
J Clin Microbiol; 1989 Sep; 27(9):1973-8. PubMed ID: 2674193
[TBL] [Abstract][Full Text] [Related]
10. Purification and physicochemical properties of a unique Vero cell cytotoxin from Escherichia coli O157:H7.
Padhye VV; Kittell FB; Doyle MP
Biochem Biophys Res Commun; 1986 Sep; 139(2):424-30. PubMed ID: 3533062
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization of A and B subunits of Shiga toxin and reconstitution of holotoxin from isolated subunits.
Yutsudo T; Honda T; Miwatani T; Takeda Y
Microbiol Immunol; 1987; 31(3):189-97. PubMed ID: 3302622
[TBL] [Abstract][Full Text] [Related]
12. Purification of a lethal toxin produced by Shigella dysenteriae.
Okamoto K; Takeda Y; Miwatani T
Toxicon; 1982; 20(2):451-6. PubMed ID: 7043787
[TBL] [Abstract][Full Text] [Related]
13. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.
Lindgren SW; Samuel JE; Schmitt CK; O'Brien AD
Infect Immun; 1994 Feb; 62(2):623-31. PubMed ID: 8300218
[TBL] [Abstract][Full Text] [Related]
14. Colonic hemorrhage produced in mice by a unique vero cell cytotoxin from an Escherichia coli strain that causes hemorrhagic colitis.
Padhye VV; Beery JT; Kittell FB; Doyle MP
J Infect Dis; 1987 Jun; 155(6):1249-53. PubMed ID: 3553350
[TBL] [Abstract][Full Text] [Related]
15. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK
Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179
[TBL] [Abstract][Full Text] [Related]
16. Purification of recombinant shiga-like toxin type I B subunit.
Austin PR; Hovde CJ
Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
[TBL] [Abstract][Full Text] [Related]
17. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
Brown JE; Griffin DE; Rothman SW; Doctor BP
Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
[TBL] [Abstract][Full Text] [Related]
18. Characterization of flagella purified from enterohemorrhagic, vero-cytotoxin-producing Escherichia coli serotype O157:H7.
Sherman P; Soni R; Yeger H
J Clin Microbiol; 1988 Jul; 26(7):1367-72. PubMed ID: 3045153
[TBL] [Abstract][Full Text] [Related]
19. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
Padhye VV; Zhao T; Doyle MP
J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
